Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

All Lloydspharmacy branches to receive new dispensing system next year

All Lloydspharmacy branches will receive a “state of the art” dispensing system next year, its CEO has told C+D.

The dispensing system used in its branches has not changed for 20 years, Toby Anderson, CEO of Lloydspharmacy’s parent company McKesson UK, told C+D in an exclusive interview in August.

The new system, which will be rolled out to every UK branch in 2020, will “make a real difference for pharmacists”, Mr Anderson said.

While the multiple would not give more details of how the system will work in practice, it told C+D this investment “will help improve the pharmacy experience”.

It is “excited” to share more details with Lloydspharmacy teams “in the next few months”, it added.

Read what other plans Mr Anderson has for the UK’s second largest pharmacy chain in C+D’s exclusive interview

What do you think of Mr Anderson's announcement?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006152

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel